RxDoctor Payments Data

Omar Hudson

Pediatric Endocrinology · Melbourne, FLNPI 1043417421

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (53.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 63.8% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2020 at $2,125 and has fallen 98.6% since, to $30 in 2024.

$3,341in general payments, 2019–2025

Across 76 payments — averaging $43.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$415
  • Sanofi-aventis U.S. LLC$120
  • Ascendis Pharma Endocrinology Inc$104
  • IBSA Pharma Inc.$66
  • Xeris Pharmaceuticals, Inc.$64
  • plus $440 from 14 others

What the payments were for

  • Consulting fees$1,80054%
  • Travel & lodging$933%
  • Food & beverage$1,39642%
  • Education$522%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,341 in reported general payments places this provider in the 65th percentile of 102 pediatric endocrinology providers in Florida.

See all pediatric endocrinology providers in Florida

Other pediatric endocrinology in Melbourne

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →